Percutaneous radiofrequency ablation approach through the spleen: Initial case report for pancreatic tail gastrinoma

State Key Laboratory of Oncology in South China, Guangzhou, Guangdong 510060, PR China.
Chinese journal of cancer (Impact Factor: 2.16). 09/2010; 29(9):836-41. DOI: 10.5732/cjc.009.10755
Source: PubMed


Gastrinoma has a low incidence, and the pancreas-originated gastrinoma is rare. Pancreatic gastrinoma patients with liver metastases have poor prognosis and short survival. Local treatment to reduce the tumor burden helps to improve symptoms and slows down tumor progression for patients with unresectable tumors. We report a case of pancreatic tail gastrinoma with unresectable liver metastases. The patient received a comprehensive minimally invasive interventional treatment, that is, chemoembolization and radiofrequency ablation for liver metastases, and percutaneous transplenic radiofrequency ablation combined with radioactive 125I seed implantation for pancreatic tail gastrinoma. The patient was followed up for more than 20 months, and showed no clear evidence of tumor recurrence. We explored the safety and feasibility of percutaneous transplenic radiofrequency ablation for unresectable pancreatic tail gastrinoma. This transplenic approach allow more indications for minimally invasive therapy and provides a new treatment option not only for patients with unresectable pancreatic tail tumor but also for patients refusing surgery.

Download full-text


Available from: Ming Zhao,
16 Reads
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: For patients with unresectable pancreatic cancer, current chemotherapies have negligible survival benefits. Thus, efforts to develop effective minimally invasive therapies are currently underway. This study was conducted to evaluate the results of transarterial chemoembolization plus radiofrequency ablation and/or 125I radioactive seed implantation on unresectable pancreatic cancer. We retrospectively analyzed 71 patients with unresectable pancreatic carcinoma who underwent chemoembolization plus radiofrequency ablation and/or radioactive seed implantation. Of all the 71 patients, the median survival time was 11 months, and the 1-year, 2-year and 3-year overall survival rates were 32.4%, 9.9% and 6.6%, respectively. Patients who were negative for metastasis, who had oligonodular liver metastases (n ≤ 3), and who had multinodular liver metastases (n > 3) had median survival times of 12 months, 18 months, and 8 months, respectively, and 1-year overall survival rates of 50.0%, 68.8%, and 5.7%, respectively. Patients negative for liver metastases had worse survival than did patients with stage IV disease who had oligonodular liver metastasis, but the result was not statistically significant (P = 0.239). In contrast, the negative group had significantly better survival than did patients with multinodular liver metastases (P < 0.001). Patients with oligonodular liver lesions had a statistically longer median survival time than did patients with multinodular lesions (P < 0.001). In conclusion, combined minimally invasive therapies had good survival rate for unresectable pancreatic cancer and resulted in a good control of liver metastases. In addition, the number of liver lesions was a statistically significant factor in predicting prognosis and response of treatment.
    Chinese journal of cancer 09/2012; DOI:10.5732/cjc.012.10093 · 2.16 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Unresectable locally advanced pancreatic cancer with or without metastatic disease is associated with a very poor prognosis. Ablation techniques are based on direct application of chemical, thermal, or electrical energy to a tumor, which leads to cellular necrosis. Initial studies about ablation therapies of the pancreas were associated with significant morbidity and mortality, which limited widespread adoption. Modifications to the various applications, in particular combining the techniques with high-quality imaging and intra-operative approach has enabled real-time treatment monitoring and significant improvements in safety. Inoperable cases of pancreatic cancer have been treated by various ablation techniques in the last few years with promising results. The purpose of this review is to present the current status of local ablative therapies in the treatment of pancreatic advanced tumor.
    La radiologia medica 07/2014; 119(7). DOI:10.1007/s11547-014-0417-9 · 1.34 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Within the group of Gastro-Entero-Pancreatic Neuroendocrine tumours (GEP-NETs), several heterogeneous malignancies are included with a variety of clinical manifestations and imaging characteristics. Often these cases are inoperable and minimal invasive treatment offered by image-guided procedures appears to be the only option. Interventional radiology offers a valid solution in the management of primary and metastatic GEP-NETs. The purpose of this review article is to describe the current status of the role of Interventional Radiology in the management of GEP-NETs.
    CardioVascular and Interventional Radiology 11/2014; 38(1). DOI:10.1007/s00270-014-1005-z · 2.07 Impact Factor
Show more